Retour
Fourchette du Jour
8,48 €
8,48 €
Fourchette 52 Semaines
5,83 €
10,65 €
Volume
100
Moyenne 50J / 200J
8,48 €
/
8,29 €
Clôture Précédente
8,48 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,8 | 0,4 |
| P/B | 11,9 | 2,9 |
| ROE % | -249,8 | 3,7 |
| Net Margin % | -41,3 | 3,9 |
| Rev Growth 5Y % | 197,9 | 10,0 |
| D/E | 6,3 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,17 €
0,23 € – 2,41 €
|
3,1 B | 1 |
| FY2028 |
-1,03 €
-2,12 € – -0,20 €
|
1,9 B | 1 |
| FY2027 |
-1,37 €
-2,81 € – -0,27 €
|
1,3 B | 1 |
Points Clés
Revenue grew 197,91% annually over 5 years — strong growth
Debt/Equity of 6,32 — high leverage
Negative free cash flow of -135,65M
PEG of 0,25 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 143,86%
Capital efficient — spends only 2,48% of revenue on capex
Croissance
Revenue Growth (5Y)
197,91%
Revenue (1Y)341,77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-249,80%
ROIC-14,35%
Net Margin-41,34%
Op. Margin-37,70%
Sécurité
Debt / Equity
6,32
Current Ratio1,26
Interest Coverage-5,74
Valorisation
P/E Ratio
-7,78
P/B Ratio11,94
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 341,77% | Revenue Growth (3Y) | 116,25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 197,91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 980,65M | Net Income (TTM) | -405,43M |
| ROE | -249,80% | ROA | -15,49% |
| Gross Margin | 97,03% | Operating Margin | -37,70% |
| Net Margin | -41,34% | Free Cash Flow (TTM) | -135,65M |
| ROIC | -14,35% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 6,32 | Current Ratio | 1,26 |
| Interest Coverage | -5,74 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,78 | P/B Ratio | 11,94 |
| P/S Ratio | 3,22 | PEG Ratio | 0,25 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,15B | Enterprise Value | 3,59B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 980,65M | 221,98M | 209,71M | 27,91M | 12,45M |
| Net Income | -405,43M | -925,64M | -882,92M | -782,42M | -677,61M |
| EPS (Diluted) | -1,37 | -3,28 | -3,35 | -3,07 | -3,14 |
| Gross Profit | 951,57M | 191,44M | 187,71M | 24,58M | 10,48M |
| Operating Income | -369,73M | -872,64M | -883,41M | -933,17M | -684,43M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2,62B | 2,50B | 2,83B | 2,94B | 1,73B |
| Total Liabilities | 2,34B | 2,43B | 2,42B | 1,71B | 884,42M |
| Shareholders' Equity | 264,19M | 60,42M | 408,66M | 1,23B | 846,62M |
| Total Debt | 1,67B | 1,80B | 1,79B | 1,08B | 529,70M |
| Cash & Equivalents | 1,24B | 1,07B | 1,49B | 1,74B | 1,02B |
| Current Assets | 1,47B | 1,34B | 1,64B | 1,89B | 1,08B |
| Current Liabilities | 1,17B | 934,17M | 881,15M | 361,11M | 276,15M |